Stay updated on Selinexor Combo for High-Risk Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.

Latest updates to the Selinexor Combo for High-Risk Myeloma Clinical Trial page
- Check5 days agoChange DetectedA new revision v3.5.5 was added to the study record history, indicating an update to the record. The previous revision v3.5.4 was removed from the latest history entry.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry v3.5.4 has been added to the study record history, representing an updated version of the record. The previous revision v3.5.3 is no longer listed in the version history, indicating that changes were incorporated in the new revision.SummaryDifference0.1%

- Check40 days agoChange DetectedVersion label on the Record History updated from v3.5.2 to v3.5.3. This reflects a maintenance update to the page's underlying system or formatting, not a modification to study content.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry v3.5.2 was added to the history and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed from the history.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded revision v3.4.3 to the Record History and removed revision v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Selinexor Combo for High-Risk Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.